Hubert Walinski

Directeur/Membre du Conseil chez CIPHER PHARMACEUTICALS INC.

Fortune : - $ au 30/04/2024

Health Technology

Consumer Services

Postes actifs de Hubert Walinski

Sociétés	Poste	Début	Fin
CIPHER PHARMACEUTICALS INC.	Directeur/Membre du Conseil	21/06/2023	-
CIPHER PHARMACEUTICALS INC.	Independent Dir/Board Member	21/06/2023	-
Aic Global Holdings, Inc.	Directeur Technique/Scientifique/R&D	01/08/2021	-

Sociétés	Poste	Début	Fin
AstraZeneca Canada, Inc. AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca Canada, Inc. develops and manufactures pharmaceutical drug preparations. Its therapeutic areas include cardiovascular and metabolic disease, oncology, and respiratory, inflammation and autoimmunity. The firm also active in the infection, neuroscience and gastrointestinal disease areas. The company was founded in 1999 and is headquartered in Mississauga, Canada.	Directeur Technique/Scientifique/R&D	01/01/2016	01/07/2021

University of British Columbia	Doctorate Degree
McMaster University	Undergraduate Degree

Internationale

Canada

Opérationnelle

Chief Tech/Sci/R&D Officer	2
Director/Board Member	1
Independent Dir/Board Member	1

Sectorielle

Health Technology	3
Consumer Services	3

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	1
CIPHER PHARMACEUTICALS INC.	Health Technology

Entreprise privées	2
Aic Global Holdings, Inc.
AstraZeneca Canada, Inc. AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca Canada, Inc. develops and manufactures pharmaceutical drug preparations. Its therapeutic areas include cardiovascular and metabolic disease, oncology, and respiratory, inflammation and autoimmunity. The firm also active in the infection, neuroscience and gastrointestinal disease areas. The company was founded in 1999 and is headquartered in Mississauga, Canada.	Health Technology

Entreprise privées

Aic Global Holdings, Inc.

Health Technology